Certis Oncology Solutions, a precision oncology and translational sciences company, announced it will make available its personalized approach to drug efficacy testing to the commercial pharmaceutical industry. This press release features multimedia. More than half of all new cancer drugs fail in clinical trials due to problems with efficacy, said Peter Ellman, Certis Oncology CEO.
Insights from 230 clinical operations leaders on implementing technology in clinical trials over the next three years Florence Healthcare, the leading platform for electronic document and data workflow management and remote connectivity in clinical trials, released today its annual State of Clinical Trial Technology Industry Report.
The cell culture protein surface coating market is poised to grow by USD 439.68 million during 2020-2024, progressing at a CAGR of almost 13% during the forecast period. This press release features multimedia. Worried about the impact of COVID-19 on your Business? Get FREE Sample Report in Minutes!
News, commentary and research reports are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.
PDF’s require Adobe® Reader® and will open in a new window.
